Phase 2 studies of adenosine cardioplegia

Autor: G, Cohen, R, Feder-Elituv, J, Iazetta, P, Bunting, H, Mallidi, J, Bozinovski, C, Deemar, G T, Christakis, E A, Cohen, B I, Wong, R D, McLean, M, Myers, C D, Morgan, C D, Mazer, T S, Smith, B S, Goldman, C D, Naylor, S E, Fremes

Publikováno v: Circulation. 98

Laboratory evidence supports the use of adenosine-supplemented cardioplegia. An initial phase 1 dose-ranging clinical evaluation demonstrated that an adenosine concentration of 15 mumol/L could be safely administered with warm blood cardioplegia and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6e0123f5a53e9bf4ec9cb65216d4aa80
https://pubmed.ncbi.nlm.nih.gov/9852907

Phase 2 studies of adenosine cardioplegia.

Autor: Cohen G; Division of Cardiovascular Surgery, Sunnybrook Health Science Center, University of Toronto, Canada., Feder-Elituv R, Iazetta J, Bunting P, Mallidi H, Bozinovski J, Deemar C, Christakis GT, Cohen EA, Wong BI, McLean RD, Myers M, Morgan CD, Mazer CD, Smith TS, Goldman BS, Naylor CD, Fremes SE

Publikováno v: Circulation [Circulation] 1998 Nov 10; Vol. 98 (19 Suppl), pp. II225-33.